Role of organoid research in the biological benefit-dominated diagnosis and treatment of biliary tract carcinoma
Biliary tract carcinoma(BTC) is a highly malignant tumor with a poor prognosis. Although radical surgical resection remains the only curative treatment, only 20% of patients are eligible for curative resection. In recent years, comprehensive treatments combining chemotherapy with immunotherapy and t...
Saved in:
| Main Author: | QI Zhong, CHENG Shi |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Surgery Concepts & Practice
2025-03-01
|
| Series: | Waike lilun yu shijian |
| Subjects: | |
| Online Access: | https://www.qk.sjtu.edu.cn/jscp/fileup/1007-9610/PDF/1751876334910-925139371.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevention and management of immune-related adverse events for biliary tract cancers
by: LIU Kun, GUO Wei
Published: (2025-03-01) -
Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report
by: Ryosuke Takayanagi, et al.
Published: (2017-11-01) -
Clinical significance of HER2 overexpression in biliary tract carcinoma ——a meta analysis
by: Haonan Xu, et al.
Published: (2025-05-01) -
Cholangiocyte organoids for disease, cancer, and regenerative medicine
by: Munemasa Nagao, et al.
Published: (2025-03-01) -
Proceedings of clinical trials on bile tract cancer
by: XIONG Yichen, YANG Ziyi, SANG Yuer, GONG Wei
Published: (2024-09-01)